Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 1 study of single-dose MVT-602 in healthy premenopausal women
NL-OMON44304Phase 1Active, not recruiting
- Sponsor
- Myovant Sciences
- Start
- Oct 2017
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial in female infertility and anovulation comparing MVT-602 with Placebo (2 arms). Primary endpoint: Safety and tolerability. Started Oct 2017; status: active, not recruiting.
02
Drugs
TAK-448
03
Conditions
female infertilityanovulation
Beyond the preview
Go deeper on NL-OMON44304.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON44304.